361 related articles for article (PubMed ID: 10588403)
1. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
[TBL] [Abstract][Full Text] [Related]
2. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
Silverstone PH; McGrath BM; Kim H
Bipolar Disord; 2005 Feb; 7(1):1-10. PubMed ID: 15654927
[TBL] [Abstract][Full Text] [Related]
3. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.
Davanzo P; Thomas MA; Yue K; Oshiro T; Belin T; Strober M; McCracken J
Neuropsychopharmacology; 2001 Apr; 24(4):359-69. PubMed ID: 11182531
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
[TBL] [Abstract][Full Text] [Related]
5. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
7. Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol.
Manji HK; Bersudsky Y; Chen G; Belmaker RH; Potter WZ
Neuropsychopharmacology; 1996 Oct; 15(4):370-81. PubMed ID: 8887991
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology of lithium: an update.
Lenox RH; McNamara RK; Papke RL; Manji HK
J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
[TBL] [Abstract][Full Text] [Related]
9. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
Neuroreport; 2006 Aug; 17(12):1323-6. PubMed ID: 16951578
[TBL] [Abstract][Full Text] [Related]
10. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
11. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
12. Acute intracerebroventricular inositol does not reverse the effect of chronic lithium treatment in the forced swim test.
Toker L; Kara N; Hadas I; Einat H; Bersudsky Y; Belmaker RH; Agam G
Neuropsychobiology; 2013; 68(3):189-92. PubMed ID: 24157652
[TBL] [Abstract][Full Text] [Related]
13. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS.
Silverstone PH; Hanstock CC; Fabian J; Staab R; Allen PS
Biol Psychiatry; 1996 Aug; 40(4):235-46. PubMed ID: 8871769
[TBL] [Abstract][Full Text] [Related]
14. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.
Shimon H; Agam G; Belmaker RH; Hyde TM; Kleinman JE
Am J Psychiatry; 1997 Aug; 154(8):1148-50. PubMed ID: 9247405
[TBL] [Abstract][Full Text] [Related]
15. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?
Moore GJ; Bebchuk JM; Hasanat K; Chen G; Seraji-Bozorgzad N; Wilds IB; Faulk MW; Koch S; Glitz DA; Jolkovsky L; Manji HK
Biol Psychiatry; 2000 Jul; 48(1):1-8. PubMed ID: 10913502
[TBL] [Abstract][Full Text] [Related]
16. Effects of lithium on phosphoinositide metabolism in vivo.
Sherman WR; Gish BG; Honchar MP; Munsell LY
Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
[TBL] [Abstract][Full Text] [Related]
17. Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.
Patel NC; DelBello MP; Cecil KM; Adler CM; Bryan HS; Stanford KE; Strakowski SM
Biol Psychiatry; 2006 Nov; 60(9):998-1004. PubMed ID: 17056394
[TBL] [Abstract][Full Text] [Related]
18. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory.
Belmaker RH; Bersudsky Y; Agam G; Levine J; Kofman O
Annu Rev Med; 1996; 47():47-56. PubMed ID: 8712796
[TBL] [Abstract][Full Text] [Related]
19. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608
[TBL] [Abstract][Full Text] [Related]
20. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
